BMKDF 0.20 BioMark Diagnostics Inc.
| Range: | 0.1335-0.2303 | Vol Avg: | 2172 | Last Div: | 0 | Changes: | 0.05 |
| Beta: | -0.54 | Cap: | 0.02B | Currency: | USD | Exchange: | PNK |
| Sector: | Healthcare | IPO: | Mon Mar 23 2015 | Empoloyees: | |||
| CUSIP: | CIK: | ISIN: | CA09073K1084 | Country: | CA | ||
| CEO: | Mr. Rashid Ahmed Maula Bux B.Sc., MBA | Website: | https://www.biomarkdiagnostics.com | ||||
BioMark Diagnostics Inc., an oncology focused company, develops cancer diagnostic solutions to detect, monitor, and assess early treatment. It has a collaborative research agreement with the Icahn School of Medicine for clinical studies related to early lung cancer diagnosis. The company was incorporated in 2014 and is headquartered in Richmond, Canada. BioMark Diagnostics Inc. is a subsidiary of Biomark Technologies Inc.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow